Home › Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals
 

Keywords :   


Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals

2015-08-30 19:41:11| Biotech - Topix.net

's stock had its "buy" rating restated by research analysts at Canaccord Genuity in a research report issued on Wednesday, Market Beat Ratings reports. They presently have a $700.00 price target on the biopharmaceutical company's stock, up from their previous price target of $600.00.

Tags: buy rating pharmaceuticals reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »